Post Aca6KXK5Mkx2S89p68 by AnonymousFrog@noagendasocial.com
 (DIR) More posts by AnonymousFrog@noagendasocial.com
 (DIR) Post #Aca6F9WyOgnrDNcOoa by AnonymousFrog@noagendasocial.com
       2023-12-07T23:22:11Z
       
       0 likes, 1 repeats
       
       ‘[O]n March 28, 2019, six months before COVID-19 would ultimately kick in, the government-funded Cambridge, Massachusetts, biotech start-up Moderna amended its previously rejected patent application for its mRNA vaccine platform to seek federal patent approval for a coronavirus vaccine with renewed urgency.28,29 Moderna begged the US Patent Office to act with alacrity, citing “a concern for re-emergence or a deliberate release of the SARS coronavirus.”30’
       
 (DIR) Post #Aca6KXK5Mkx2S89p68 by AnonymousFrog@noagendasocial.com
       2023-12-07T23:23:08Z
       
       0 likes, 0 repeats
       
       “Moderna’s CEO, Stéphane Bancel, had some inside knowledge that may have informed that extraordinarily prescient appeal. Bancel, as the former CEO of bioMérieux, the French company that built the $44 million Wuhan Institute of Virology, a biosafety level 4 (BSL-4) lab,31,32 likely had insider knowledge of the lab’s reported difficulties with the critical airflow system required to keep transmissible viruses from escaping.33,34”